Skip to the page

Data / Public companies / SIC 3842: Orthopedic, prosthetic and surgical appliances and supplies / Cuprina Holdings (cayman) LTD

Cuprina Holdings (cayman) LTD: revenue, net income and total assets from its latest annual report

Updated April 27, 2026. Source: SEC Financial Statement Data Sets, filing 0001493152-26-019085.

Cuprina Holdings (cayman) LTD reported revenue of $38,789, a net loss of $3.6 million and total assets of $6.6 million for the fiscal year ended December 31, 2025, in its annual report (20-F) filed with the SEC on April 27, 2026. It ranks 27th by revenue of 28 companies in SIC 3842, orthopedic, prosthetic and surgical appliances and supplies.

The request: Watch Cuprina Holdings (cayman) LTD (CIK 1995704): each new SEC filing, with revenue and net income. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.

SEC central index key (CIK)
1995704
Industry
SIC 3842, Orthopedic, prosthetic and surgical appliances and supplies
Business address (city and state)
Singapore, Singapore
Incorporated in
Kentucky
Filer category
Non-accelerated filer
Fiscal year ends
December 31
Latest annual report
20-F filed April 27, 2026
Annual and quarterly reports in the data
1 annual, 0 quarterly

Financials for the fiscal year ended December 31, 2025

As filed, in US dollars. The prior year value is the comparison column in the same report.

ItemThis yearPrior yearChangeSource
Revenue$38,789Not listedNot listedsec.gov
Operating income$-3,754,823Not listedNot listedsec.gov
Net income$-3,633,248Not listedNot listedsec.gov
Total assets$6,611,675Not listedNot listedsec.gov
Total liabilities$2,681,467Not listedNot listedsec.gov
Stockholders' equity$3,930,208Not listedNot listedsec.gov
Cash and cash equivalents$2,423,760Not listedNot listedsec.gov

How it compares

Net margin (net income over revenue)
-9366.7%
Revenue rank in SIC 3842
27th of 28
Revenue rank among all companies in the data
4,384th of 4,486

Companies next to it by revenue in SIC 3842

Orthopedic, prosthetic and surgical appliances and supplies, from the same data.

CompanyBusiness addressRevenueNet incomeTotal assetsRevenue change
Envue Medical, Inc.Tyler, TX$2.6 million$-18,185,000$41.1 million-0.2%
Collplant Biotechnologies LTDRehovot, Israel$2.4 million$-11,489,000$10.8 million360.4%
Nutriband Inc.Orlando, FL$2 million$-8,229,632$7.5 million-4.8%
Anteris Technologies Global Corp.Eagan, MN$1.9 million$-94,144,000$23 million-29.2%
Safe Pro Group Inc.Aventura, FL$606,681$-14,322,779$19.1 million-72%
Envoy Medical, Inc.White Bear Lake, MN$241,000$-23,756,000$8.6 million7.1%
Axe Compute Inc.Pittsburgh, PA$125,284$-233,095,203$52.9 million47.7%
Heartsciences Inc.Southlake, TX$4,319$-9,141,875Not listed-0.7%

Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.